García-Nafría, Javier
Nehmé, Rony
Edwards, Patricia C.
Tate, Christopher G.
Article History
Received: 16 February 2018
Accepted: 22 May 2018
First Online: 20 June 2018
Competing interests
: C.G.T. is a shareholder, consultant and member of the Scientific Advisory Board of Heptares Therapeutics, who also partly funded this work.